Streetbeat News

Analyst Ratings

OMGA

HC Wainwright & Co. analyst Robert Burns has reaffirmed a Buy rating on Omega Therapeutics (NASDAQ:OMGA) and increased the price target from $11 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 4:18 pm

SVRA

HC Wainwright & Co. analyst Andrew Fein has reiterated a Buy rating on Savara (NASDAQ:SVRA) and maintained a price target of $6. The reaffirmation of the Buy rating and price target suggests a positive outlook for Savara's stock.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 4:17 pm

ONCY

HC Wainwright & Co. analyst Patrick Trucchio has maintained a Buy rating on Oncolytics Biotech (NASDAQ:ONCY) but has reduced the price target from $15 to $5.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 4:16 pm

TPR

JP Morgan analyst Matthew Boss has maintained an Overweight rating on Tapestry (NYSE:TPR) but reduced the price target from $56 to $41.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 4:05 pm

RXRX

JP Morgan analyst Eric Joseph has maintained a Neutral rating on Recursion Pharmaceuticals (NASDAQ:RXRX) but has lowered the price target from $11 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 4:03 pm

DBVT

HC Wainwright & Co. analyst Andrew Fein has reiterated a Buy rating on DBV Technologies (NASDAQ:DBVT) and maintained a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 4:01 pm

U

Unity Software (NYSE:U) has received mixed analyst ratings in the last quarter, with 6 bullish, 2 somewhat bullish, 7 indifferent, and no bearish ratings. The average 12-month price target among 15 analysts is $36.07, with a high of $56.00 and a low of $20.00. This target has decreased by 19.54% from the previous average of $44.83. Analyst ratings are based on financial analysis and are important for traders to consider, though they are not infallible predictions.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 4:00 pm

MGM

Analysts have recently provided ratings for MGM Resorts Intl (NYSE:MGM), with 3 bullish, 2 somewhat bullish, and 3 indifferent ratings in the last quarter. The average 12-month price target among 8 analysts is $48.75, with a high of $55.00 and a low of $40.00, representing a 5.65% decrease from the previous target of $51.67. Analyst ratings are opinions on stock performance and are updated quarterly.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 4:00 pm

PINC

JP Morgan analyst Anne Samuel has maintained a Neutral rating on Premier (NASDAQ:PINC) and lowered the price target from $26 to $21.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 4:00 pm

MDGL

Madrigal Pharmaceuticals (NASDAQ:MDGL) received 6 analyst ratings in the last quarter with an average price target of $249.67, representing an upside from the current price of $139.66. The new average price target is a 9.21% decrease from the previous target of $275.00. Ratings included 3 bullish, 1 somewhat bullish, and 2 indifferent, with no bearish or somewhat bearish ratings.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 4:00 pm